The Medicines (MDCO) Lifted to Sell at BidaskClub


A number of other research analysts also recently commented on the company. Jefferies Group reiterated a buy rating and issued a $54.00 price objective on shares of The Medicines in a report on Thursday, October 26th.



from Biotech News